Bevacizumab (BEV) in combination with temozolomide (TMZ) and radiation therapy (XRT) followed by BEV, TMZ, and irinotecan for newly diagnosed glioblastoma multiforme (GBM).


Journal Article

Full Text

Duke Authors

Cited Authors

  • Vredenburgh, JJ; Desjardins, A; Reardon, DA; Peters, K; Kirkpatrick, J; Herndon, JE; Marcello, J; Bailey, L; Threatt, S; Friedman, HS

Published Date

  • May 20, 2010

Published In

Volume / Issue

  • 28 / 15_suppl

Start / End Page

  • 2023 - 2023

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2010.28.15_suppl.2023


  • en